Shanghai Xuerong BiotechnologyLtd Past Earnings Performance
Past criteria checks 0/6
Shanghai Xuerong BiotechnologyLtd's earnings have been declining at an average annual rate of -56%, while the Food industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 4.7% per year.
Key information
-56.0%
Earnings growth rate
-55.7%
EPS growth rate
| Food Industry Growth | 7.2% |
| Revenue growth rate | 4.7% |
| Return on equity | -17.2% |
| Net Margin | -9.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Shares Fly 48% But Investors Aren't Buying For Growth
Oct 08
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Price Is Right But Growth Is Lacking After Shares Rocket 45%
Aug 19Little Excitement Around Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Revenues As Shares Take 31% Pounding
Jun 27There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise
May 13Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry
Mar 15Revenue & Expenses Breakdown
How Shanghai Xuerong BiotechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,263 | -224 | 109 | 4 |
| 30 Jun 24 | 2,261 | -373 | 166 | 5 |
| 31 Mar 24 | 2,327 | -406 | 220 | 6 |
| 31 Dec 23 | 2,565 | -188 | 243 | 7 |
| 30 Sep 23 | 2,615 | -421 | 278 | 8 |
| 30 Jun 23 | 2,722 | -145 | 227 | 8 |
| 31 Mar 23 | 2,587 | -122 | 163 | 8 |
| 01 Jan 23 | 2,320 | -287 | 139 | 7 |
| 30 Sep 22 | 2,293 | -190 | 166 | 7 |
| 30 Jun 22 | 2,118 | -342 | 138 | 9 |
| 31 Mar 22 | 2,083 | -356 | 152 | 11 |
| 01 Jan 22 | 2,073 | -312 | 153 | 14 |
| 30 Sep 21 | 2,068 | -85 | 171 | 15 |
| 30 Jun 21 | 2,135 | 21 | 199 | 14 |
| 31 Mar 21 | 2,168 | 179 | 172 | 14 |
| 31 Dec 20 | 2,202 | 247 | 176 | 12 |
| 30 Sep 20 | 2,208 | 327 | 156 | 12 |
| 30 Jun 20 | 2,077 | 260 | 140 | 11 |
| 31 Mar 20 | 2,029 | 254 | 147 | 11 |
| 31 Dec 19 | 1,965 | 220 | 130 | 11 |
| 30 Sep 19 | 1,861 | 128 | 110 | 12 |
| 30 Jun 19 | 1,923 | 236 | 109 | 11 |
| 31 Mar 19 | 1,841 | 176 | 115 | 12 |
| 31 Dec 18 | 1,847 | 151 | 118 | 11 |
| 30 Sep 18 | 1,841 | 174 | 120 | 10 |
| 30 Jun 18 | 1,668 | 113 | 106 | 13 |
| 31 Mar 18 | 1,610 | 186 | 100 | 10 |
| 31 Dec 17 | 1,330 | 122 | 100 | 7 |
| 30 Sep 17 | 1,124 | 156 | 82 | 5 |
| 30 Jun 17 | 1,044 | 133 | 96 | 0 |
| 31 Mar 17 | 985 | 101 | 89 | 0 |
| 31 Dec 16 | 999 | 105 | 85 | 0 |
| 30 Sep 16 | 1,027 | 142 | 85 | 0 |
| 30 Jun 16 | 1,048 | 148 | 91 | 0 |
| 31 Mar 16 | 1,060 | 154 | 92 | 0 |
| 31 Dec 15 | 1,019 | 123 | 96 | 0 |
| 31 Dec 14 | 888 | 95 | 93 | 0 |
| 31 Dec 13 | 773 | 79 | 91 | 0 |
Quality Earnings: 300511 is currently unprofitable.
Growing Profit Margin: 300511 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300511 is unprofitable, and losses have increased over the past 5 years at a rate of 56% per year.
Accelerating Growth: Unable to compare 300511's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300511 is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (-5.8%).
Return on Equity
High ROE: 300511 has a negative Return on Equity (-17.22%), as it is currently unprofitable.